Biosimilars Europe: Looking Ahead Into the New European Landscape

Case studies from both Switzerland and Norway on strategic management and switching studies with two keynotes from Merck Group and the Norwegian Medicines Agency. [PR.com]

Pharmaceutical Stocks

[stock-ticker]

© 2018 Drugs News All rights reserved.       Privacy Policy       Contact Us